ClassID:

20935

A61K38/1764 - CPC Classification

Classification description:

Recent Application in this class:
#1
20200223934
2020-07-16

De novo binding domain containing polypeptides and uses thereof

#2
20200009236
2020-01-09

H3.3 CTL peptides and uses thereof

#3
20190161526
2019-05-30

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

#4
20190112347
2019-04-18

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

#5
20190062389
2019-02-28

Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells

#6
20190048077
2019-02-14

Methods and compositions for the prevention and treatment of surgical adhesions

#7
20180327474
2018-11-15

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

#8
20180251563
2018-09-06

De novo binding domain containing polypeptides and uses thereof

#9
20180251521
2018-09-06

De novo binding domain containing polypeptides and uses thereof

#10
20180245088
2018-08-30

Antibody to human and mouse SEMA3A and use thereof

#11
20180185482
2018-07-05

Checkpoint regulator antagonists

#12
20180169199
2018-06-21

HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell

#13
20180169156
2018-06-21

Oral cancer vaccine

#14
20180161428
2018-06-14

Prostate specific membrane antigen binding protein

#15
20180161396
2018-06-14

T cell receptors and immune therapy using the same

#16
20180133295
2018-05-17

A Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist

#17
20180127717
2018-05-10

DENDRITIC CELL IMMUNOTHERAPY

#18
20180105567
2018-04-19

Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells

#19
20180030109
2018-02-01

Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor

#20
20170368169
2017-12-28

Multispecific and multifunctional molecules and uses thereof

#21
20170368131
2017-12-28

Immunotherapy for angiogenic disease

#22
20170342125
2017-11-30

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

#23
20170281742
2017-10-05

H3.3 CTL peptides and uses thereof

#24
20170275382
2017-09-28

Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof

#25
20170202913
2017-07-20

CTL INDUCER COMPOSITION

#26
20170189484
2017-07-06

CEACAM5 PEPTIDES FOR CROHN'S DISEASE

#27
20170173132
2017-06-22

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#28
20170096461
2017-04-06

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

#29
20170029487
2017-02-02

Selective inhibitors of c-Fos and their antiproliferative properties

#30
20160122415
2016-05-05

Methods and compositions for the treatment of cancer

#31
20150315239
2015-11-05

Method of inducing an immune response by administering WDRPUH epitope peptides

#32
20150125477
2015-05-07

Personalized immunotherapy against several neuronal and brain tumors

#33
20130315942
2013-11-28

Method of inducing an immune response by administering WDRPUH epitope peptides

#34
20130224233
2013-08-29

Immunotherapeutic method for treating prostate cancer

#35
20130142784
2013-06-06

METHOD OF TREATING TUMOR RESISTANT TO HERCEPTIN OR PACLITAXEL USING FOXM1 INHIBITORS AND DETECTING SAME

#36
20100092522
2010-04-15

Immunogenic WT-1 peptides and methods of use thereof

#37
20080187548
2008-08-07

NY-ESO-1 peptides which bind to class II molecules and uses thereof